XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 9 Months Ended
Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSETS CARRYING VALUE

 SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSETS CARRYING VALUE

       As of
September 30,
2021		   As of
December 31,
2020		 
   Life   Carrying   Carrying 
   (Years)   Amount   Amount 
       (unaudited)     
Asuragen acquisition:               
Thyroid   9   $8,519   $8,519 
RedPath acquisition:               
Pancreas test   7    16,141    16,141 
Barrett’s test   9    6,682    6,682 
BioPharma acquisition:               
Trademarks   10    1,600    1,600 
Customer relationships   8    5,700    5,700 
                
CLIA Lab   2.3    609    609 
                
Total       $39,251   $39,251 
                
Accumulated Amortization       $(31,237)  $(27,900)
                
Net Carrying Value       $8,014   $11,351 
SCHEDULE OF FUTURE ESTIMATED AMORTIZATION EXPENSE

SCHEDULE OF FUTURE ESTIMATED AMORTIZATION EXPENSE 

2021   2022   2023   2024   2025 
$1,112   $2,155   $2,099   $873   $873 
SCHEDULE OF GOODWILL CARRYING VALUE

The following table displays a roll forward of the carrying amount of goodwill from December 31, 2020 to September 30, 2021:

 

SCHEDULE OF GOODWILL CARRYING VALUE 

   Carrying 
   Amount 
Balance as of December 31, 2020  $8,433 
Adjustments   - 
Balance as of September 30, 2021  $8,433